Literature DB >> 11174635

Bone marrow transplantation for aspartylglucosaminuria: follow-up study of transplanted and non-transplanted patients.

M Arvio1, O Sauna-Aho, M Peippo.   

Abstract

We describe the state of health, intellectual skills, and dysmorphic features of 19 young patients with aspartylglucosaminuria. Of them, 5 had undergone a successful bone marrow transplantation between 1991 and 1997. The first 2 patients who received transplants were, after 7 and 5 years' follow-up, more severely mentally retarded than the non-transplanted patients. The general health of the later patients was quite good, whereas the 5 patients who underwent bone marrow transplantation had post-transplant complications. Their dysmorphic status remained unchanged. We cannot encourage bone marrow transplantation for the treatment of patients with aspartylglucosaminuria after infancy.

Entities:  

Mesh:

Year:  2001        PMID: 11174635     DOI: 10.1067/mpd.2001.110119

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Susceptibility-Weighted Imaging Findings in Aspartylglucosaminuria.

Authors:  A Tokola; M Laine; R Tikkanen; T Autti
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

3.  Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry.

Authors:  Laurent Bonesso; Monique Piraud; Céline Caruba; Emmanuel Van Obberghen; Raymond Mengual; Charlotte Hinault
Journal:  Orphanet J Rare Dis       Date:  2014-02-06       Impact factor: 4.123

Review 4.  Aspartylglycosaminuria: a review.

Authors:  Maria Arvio; Ilkka Mononen
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

5.  Pre-clinical Gene Therapy with AAV9/AGA in Aspartylglucosaminuria Mice Provides Evidence for Clinical Translation.

Authors:  Xin Chen; Sarah Snanoudj-Verber; Laura Pollard; Yuhui Hu; Sara S Cathey; Ritva Tikkanen; Steven J Gray
Journal:  Mol Ther       Date:  2020-11-11       Impact factor: 11.454

Review 6.  Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage.

Authors:  Tomáš Zárybnický; Anne Heikkinen; Salla M Kangas; Marika Karikoski; Guillermo Antonio Martínez-Nieto; Miia H Salo; Johanna Uusimaa; Reetta Vuolteenaho; Reetta Hinttala; Petra Sipilä; Satu Kuure
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

7.  A cross-sectional natural history study of aspartylglucosaminuria.

Authors:  Kimberly Goodspeed; Daniel Horton; Andrea Lowden; Peter V Sguigna; Timothy Booth; Zhiyue J Wang; Veronica Bordes Edgar
Journal:  JIMD Rep       Date:  2022-07-14

Review 8.  The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases.

Authors:  Brianna M Naumchik; Ashish Gupta; Heather Flanagan-Steet; Richard A Steet; Sara S Cathey; Paul J Orchard; Troy C Lund
Journal:  Cells       Date:  2020-06-05       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.